
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
CRISPR/Cas9 editing of Nf1 gene identifies CRMP2 as a therapeutic target in neurofibromatosis type 1-related pain that is reversed by (S)-Lacosamide
Aubin Moutal, Xiaofang Yang, Wennan Li, et al.
Pain (2017) Vol. 158, Iss. 12, pp. 2301-2319
Open Access | Times Cited: 77
Aubin Moutal, Xiaofang Yang, Wennan Li, et al.
Pain (2017) Vol. 158, Iss. 12, pp. 2301-2319
Open Access | Times Cited: 77
Showing 1-25 of 77 citing articles:
Neurofibromin Structure, Functions and Regulation
Mohammed Bergoug, Michel Doudeau, Fabienne Godin, et al.
Cells (2020) Vol. 9, Iss. 11, pp. 2365-2365
Open Access | Times Cited: 121
Mohammed Bergoug, Michel Doudeau, Fabienne Godin, et al.
Cells (2020) Vol. 9, Iss. 11, pp. 2365-2365
Open Access | Times Cited: 121
Lacosamide in patients with Nav1.7 mutations-related small fibre neuropathy: a randomized controlled trial
Bianca T. A. de Greef, Janneke G. J. Hoeijmakers, Margot Geerts, et al.
Brain (2018) Vol. 142, Iss. 2, pp. 263-275
Open Access | Times Cited: 103
Bianca T. A. de Greef, Janneke G. J. Hoeijmakers, Margot Geerts, et al.
Brain (2018) Vol. 142, Iss. 2, pp. 263-275
Open Access | Times Cited: 103
Pain relief in a neuropathy patient by lacosamide: Proof of principle of clinical translation from patient-specific iPS cell-derived nociceptors
Barbara Namer, Diana Schmidt, Esther Eberhardt, et al.
EBioMedicine (2018) Vol. 39, pp. 401-408
Open Access | Times Cited: 92
Barbara Namer, Diana Schmidt, Esther Eberhardt, et al.
EBioMedicine (2018) Vol. 39, pp. 401-408
Open Access | Times Cited: 92
Biomaterials as vectors for the delivery of CRISPR–Cas9
Joon Eoh, Luo Gu
Biomaterials Science (2019) Vol. 7, Iss. 4, pp. 1240-1261
Closed Access | Times Cited: 82
Joon Eoh, Luo Gu
Biomaterials Science (2019) Vol. 7, Iss. 4, pp. 1240-1261
Closed Access | Times Cited: 82
Inherent and Composite Hydrogels as Promising Materials to Limit Antimicrobial Resistance
Rahela Carpa, Alexei Remizovschi, Carla Andreea Culda, et al.
Gels (2022) Vol. 8, Iss. 2, pp. 70-70
Open Access | Times Cited: 49
Rahela Carpa, Alexei Remizovschi, Carla Andreea Culda, et al.
Gels (2022) Vol. 8, Iss. 2, pp. 70-70
Open Access | Times Cited: 49
Emerging therapeutic targets for neurofibromatosis type 1
James A. Walker, Meena Upadhyaya
Expert Opinion on Therapeutic Targets (2018) Vol. 22, Iss. 5, pp. 419-437
Open Access | Times Cited: 72
James A. Walker, Meena Upadhyaya
Expert Opinion on Therapeutic Targets (2018) Vol. 22, Iss. 5, pp. 419-437
Open Access | Times Cited: 72
Dysregulation of CRMP2 Post-Translational Modifications Drive Its Pathological Functions
Aubin Moutal, Katherine A. White, Aude Chefdeville, et al.
Molecular Neurobiology (2019) Vol. 56, Iss. 10, pp. 6736-6755
Open Access | Times Cited: 68
Aubin Moutal, Katherine A. White, Aude Chefdeville, et al.
Molecular Neurobiology (2019) Vol. 56, Iss. 10, pp. 6736-6755
Open Access | Times Cited: 68
Harnessing nanoparticles for the efficient delivery of the CRISPR/Cas9 system
Hossein Rahimi, Marziyeh Salehiabar, Jalil Charmi, et al.
Nano Today (2020) Vol. 34, pp. 100895-100895
Closed Access | Times Cited: 64
Hossein Rahimi, Marziyeh Salehiabar, Jalil Charmi, et al.
Nano Today (2020) Vol. 34, pp. 100895-100895
Closed Access | Times Cited: 64
A porcine model of neurofibromatosis type 1 that mimics the human disease
Katherine A. White, Vicki J. Swier, Jacob T. Cain, et al.
JCI Insight (2018) Vol. 3, Iss. 12
Open Access | Times Cited: 58
Katherine A. White, Vicki J. Swier, Jacob T. Cain, et al.
JCI Insight (2018) Vol. 3, Iss. 12
Open Access | Times Cited: 58
Inhibition of the Ubc9 E2 SUMO-conjugating enzyme–CRMP2 interaction decreases NaV1.7 currents and reverses experimental neuropathic pain
Liberty François‐Moutal, Erik T. Dustrude, Yue Wang, et al.
Pain (2018) Vol. 159, Iss. 10, pp. 2115-2127
Open Access | Times Cited: 57
Liberty François‐Moutal, Erik T. Dustrude, Yue Wang, et al.
Pain (2018) Vol. 159, Iss. 10, pp. 2115-2127
Open Access | Times Cited: 57
P2X receptors and acupuncture analgesia
Yong Tang, Haiyan Yin, Juan Liu, et al.
Brain Research Bulletin (2018) Vol. 151, pp. 144-152
Open Access | Times Cited: 48
Yong Tang, Haiyan Yin, Juan Liu, et al.
Brain Research Bulletin (2018) Vol. 151, pp. 144-152
Open Access | Times Cited: 48
CRMP2 and voltage-gated ion channels: potential roles in neuropathic pain
Lindsey A. Chew, Rajesh Khanna
Neuronal Signaling (2018) Vol. 2, Iss. 1
Open Access | Times Cited: 47
Lindsey A. Chew, Rajesh Khanna
Neuronal Signaling (2018) Vol. 2, Iss. 1
Open Access | Times Cited: 47
Electrosprayed Alginate Nanoparticles as CRISPR Plasmid DNA Delivery Carrier: Preparation, Optimization, and Characterization
Batoul Alallam, Sara Altahhan, Muhammad Taher, et al.
Pharmaceuticals (2020) Vol. 13, Iss. 8, pp. 158-158
Open Access | Times Cited: 42
Batoul Alallam, Sara Altahhan, Muhammad Taher, et al.
Pharmaceuticals (2020) Vol. 13, Iss. 8, pp. 158-158
Open Access | Times Cited: 42
Differential effect of lacosamide on Nav1.7 variants from responsive and non-responsive patients with small fibre neuropathy
Julie I. R. Labau, Mark Estación, Brian S. Tanaka, et al.
Brain (2020) Vol. 143, Iss. 3, pp. 771-782
Open Access | Times Cited: 39
Julie I. R. Labau, Mark Estación, Brian S. Tanaka, et al.
Brain (2020) Vol. 143, Iss. 3, pp. 771-782
Open Access | Times Cited: 39
Advances in Genome Editing and Application to the Generation of Genetically Modified Rat Models
Vanessa Chenouard, Séverine Rémy, Laurent Tesson, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 38
Vanessa Chenouard, Séverine Rémy, Laurent Tesson, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 38
Insular cortex stimulation alleviates neuropathic pain through changes in the expression of collapsin response mediator protein 2 involved in synaptic plasticity
Kyeongmin Kim, Guanghai Nan, Hyeji Bak, et al.
Neurobiology of Disease (2024) Vol. 194, pp. 106466-106466
Open Access | Times Cited: 4
Kyeongmin Kim, Guanghai Nan, Hyeji Bak, et al.
Neurobiology of Disease (2024) Vol. 194, pp. 106466-106466
Open Access | Times Cited: 4
Cdk5-mediated CRMP2 phosphorylation is necessary and sufficient for peripheral neuropathic pain
Aubin Moutal, Shizhen Luo, Tally M. Largent‐Milnes, et al.
Neurobiology of Pain (2018) Vol. 5, pp. 100022-100022
Open Access | Times Cited: 45
Aubin Moutal, Shizhen Luo, Tally M. Largent‐Milnes, et al.
Neurobiology of Pain (2018) Vol. 5, pp. 100022-100022
Open Access | Times Cited: 45
Phosphorylated CRMP2 Regulates Spinal Nociceptive Neurotransmission
Jie Yu, Aubin Moutal, Angie Dorame, et al.
Molecular Neurobiology (2018) Vol. 56, Iss. 7, pp. 5241-5255
Open Access | Times Cited: 43
Jie Yu, Aubin Moutal, Angie Dorame, et al.
Molecular Neurobiology (2018) Vol. 56, Iss. 7, pp. 5241-5255
Open Access | Times Cited: 43
Targeting the CaVα–CaVβ interaction yields an antagonist of the N-type CaV2.2 channel with broad antinociceptive efficacy
Rajesh Khanna, Jie Yu, Xiaofang Yang, et al.
Pain (2019) Vol. 160, Iss. 7, pp. 1644-1661
Open Access | Times Cited: 39
Rajesh Khanna, Jie Yu, Xiaofang Yang, et al.
Pain (2019) Vol. 160, Iss. 7, pp. 1644-1661
Open Access | Times Cited: 39
Towards a neurobiological understanding of pain in neurofibromatosis type 1: mechanisms and implications for treatment
Shreya S. Bellampalli, Rajesh Khanna
Pain (2019) Vol. 160, Iss. 5, pp. 1007-1018
Open Access | Times Cited: 38
Shreya S. Bellampalli, Rajesh Khanna
Pain (2019) Vol. 160, Iss. 5, pp. 1007-1018
Open Access | Times Cited: 38
Small molecule targeting NaV1.7 via inhibition of the CRMP2-Ubc9 interaction reduces pain in chronic constriction injury (CCI) rats
Jiahe Li, Harrison J. Stratton, Sabina A. Lorca, et al.
Channels (2022) Vol. 16, Iss. 1, pp. 1-8
Open Access | Times Cited: 19
Jiahe Li, Harrison J. Stratton, Sabina A. Lorca, et al.
Channels (2022) Vol. 16, Iss. 1, pp. 1-8
Open Access | Times Cited: 19
Chronic pain recruits hypothalamic dynorphin/kappa opioid receptor signalling to promote wakefulness and vigilance
Hisakatsu Ito, Edita Navratilova, Barbora Vagnerova, et al.
Brain (2022) Vol. 146, Iss. 3, pp. 1186-1199
Open Access | Times Cited: 19
Hisakatsu Ito, Edita Navratilova, Barbora Vagnerova, et al.
Brain (2022) Vol. 146, Iss. 3, pp. 1186-1199
Open Access | Times Cited: 19
Intranasal CRMP2-Ubc9 inhibitor regulates NaV1.7 to alleviate trigeminal neuropathic pain
Santiago Loya‐López, Heather N. Allen, Paz Duran, et al.
Pain (2023)
Open Access | Times Cited: 12
Santiago Loya‐López, Heather N. Allen, Paz Duran, et al.
Pain (2023)
Open Access | Times Cited: 12
NF1 Is a Direct G Protein Effector Essential for Opioid Signaling to Ras in the Striatum
Keqiang Xie, Lesley A. Colgan, Maria Dao, et al.
Current Biology (2016) Vol. 26, Iss. 22, pp. 2992-3003
Open Access | Times Cited: 37
Keqiang Xie, Lesley A. Colgan, Maria Dao, et al.
Current Biology (2016) Vol. 26, Iss. 22, pp. 2992-3003
Open Access | Times Cited: 37
CRMP2–Neurofibromin Interface Drives NF1-related Pain
Aubin Moutal, Li Sun, Xiaofang Yang, et al.
Neuroscience (2018) Vol. 381, pp. 79-90
Open Access | Times Cited: 37
Aubin Moutal, Li Sun, Xiaofang Yang, et al.
Neuroscience (2018) Vol. 381, pp. 79-90
Open Access | Times Cited: 37